GlassScriptPhysician profile
Sobha Panicker-Thomas
NPI 1134678022
$2,203.29
in general payments reported to CMS, 2019-2025
15 companies · $729 in 2025
The $729 reported for 2025 was more than what 79% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $527 · 2023: $391 · 2024: $429 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,548.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $602.48 | 2024-2025 | Airsupra, Tezspire |
| Abbvie INC. | $390.82 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $330.62 | 2021-2024 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $201.67 | 2023-2025 | Rexulti, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $169.44 | 2024 | Invega Sustenna |
| Kyowa Kirin, INC. | $124.99 | 2022 | |
| Urovant Sciences INC | $82.94 | 2021 | |
| Glaxosmithkline, LLC. | $66.44 | 2024-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Emd Serono, INC. | $65.29 | 2024 | Serostim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.39 | 2025 | Ofev |
| Philips North America LLC | $30.24 | 2025 | Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $26.50 | 2025 | Glassia |
| Teva Pharmaceuticals USA, INC. | $25.50 | 2024 | Austedo Xr |
| Vanda Pharmaceuticals INC. | $23.42 | 2024 | Fanapt |
| Acadia Pharmaceuticals INC | $21.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sobha Panicker-Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.